Protection from asthma in a high-risk birth cohort by attenuated P2X 7 function

David M. Manthei, Daniel J. Jackson, Michael D. Evans, Ronald E. Gangnon, Christopher J. Tisler, James E. Gern, Robert F. Lemanske, Loren C. Denlinger

Research output: Contribution to journalArticlepeer-review

27 Scopus citations


Background: Viral illnesses are important factors in both asthma inception and exacerbations, and allergic sensitization in early life further enhances asthma risk through unclear mechanisms. Cellular damage caused by infection or allergen inhalation increases ATP levels in the airways with subsequent purinergic receptor activation. The purinergic receptor P2X 7 can enhance airway leukocyte recruitment to the airways, and P2X 7 knockout mice display a reduced asthma-like phenotype. Objective: Based on the P2X 7 knockout mouse, we hypothesized that children with low P2X 7 function would have decreased rates of asthma. Methods: We used a functional assay to determine P2X 7 pore-producing capacity in whole-blood samples in a birth cohort at high risk for asthma development. The P2X 7 assay was validated with known loss-of-function alleles in human subjects. P2X 7 pore status categorization was used to assess asthma and allergy status in the cohort. Results: Attenuated P2X 7 function was associated with lower asthma rates at ages 6 and 8 years, and the greatest effects were observed in boys. Children with asthma at age 11 years who had low P2X 7 capacity had less severe disease in the previous year. Attenuated P2X 7 function was also associated with sensitization to fewer aeroallergens. Conclusion: P2X 7 functional capacity is associated with asthma risk or disease severity, and these relationships appear to be age related.

Original languageEnglish (US)
Pages (from-to)496-502
Number of pages7
JournalJournal of Allergy and Clinical Immunology
Issue number2
StatePublished - Aug 2012
Externally publishedYes

Bibliographical note

Funding Information:
Supported by National Institutes of Health grants P01 HL070831 and K23 HL081492 , and the project described was supported by the Clinical and Translational Science Award (CTSA) program , previously through the National Center for Research Resources (NCRR) , grant 1UL1RR025011 , and now through the National Center for Advancing Translational Sciences (NCATS) , grant 9U54TR000021 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.


  • ATP
  • Asthma
  • P2X
  • allergy
  • children


Dive into the research topics of 'Protection from asthma in a high-risk birth cohort by attenuated P2X 7 function'. Together they form a unique fingerprint.

Cite this